CRH upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst Cedar Ekblom upgraded CRH to Overweight from Equal Weight with a price target of $88, up from $87. The firm says the company’ “pricing stickiness” supports its estimates which are 4%-5% ahead of consensus. CRH also offers acquisition growth “optionality” and “discounted exposure to attractive verticals” post the re-rating of the shares, the analyst tells investors in a research note.